Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the stock exchanges about a newspaper advertisement published in Business Standard on April 3, 2025, regarding the loss of an equity share certificate. The certificate belongs to the estate of deceased shareholder Prabhakar Rao Kulkarni (held jointly with Dilip Pangit and Dr. Ramkrishna Satwalekar). The certificate covers 41,550 equity shares under Folio No. 0071249, Certificate No. 9934, with distinctive numbers 59446312–59487861. The company is inviting any claims from third parties within 15 days, after which it will proceed to issue a duplicate share certificate. The filing is made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements.
This is a routine compliance disclosure with no material impact on the company's financials, operations, or share price. It is a standard procedure when a shareholder reports a lost share certificate before a duplicate can be issued.